Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Bayer ( (DE:BAYN) ) is now available.
Bayer AG announced a transaction involving Rodrigo Peixoto dos Santos, a member of its managing body, who purchased shares as part of a commitment by the Board of Management to buy Bayer AG shares. This transaction, conducted on the XETRA platform, reflects the company’s ongoing efforts to align management interests with shareholder value, potentially impacting market perceptions and investor confidence.
The most recent analyst rating on (DE:BAYN) stock is a Hold with a EUR30.00 price target. To see the full list of analyst forecasts on Bayer stock, see the DE:BAYN Stock Forecast page.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life science fields of health care and agriculture. The company is known for its pharmaceutical products, consumer health solutions, and crop science innovations, focusing on enhancing human and plant health.
Average Trading Volume: 3,583,594
Technical Sentiment Signal: Hold
Current Market Cap: €27.03B
For an in-depth examination of BAYN stock, go to TipRanks’ Overview page.